{
    "eid": "2-s2.0-85103105366",
    "title": "Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients",
    "cover-date": "2021-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Epidermal growth factor receptor (EGFR) mutation",
        "Epithelial mesenchymal transition (EMT)",
        "Non-small cell lung cancer (NSCLC)",
        "Vimentin, brain metastasis (BM)"
    ],
    "authors": [
        "Rattanawadee Teocharoen",
        "Komkrit Ruangritchankul",
        "Chanida Vinayanuwattikun",
        "Virote Sriuranpong",
        "Piyada Sitthideatphaiboon"
    ],
    "citedby-count": 3,
    "ref-count": 30,
    "ref-list": [
        "Lung Cancer Statistics",
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Cancer statistics, 2019",
        "Treatment of brain metastases from lung cancer: Chemotherapy",
        "EGFR mutation and brain metastasis in pulmonary adenocarcinomas",
        "Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer",
        "The correlation between EGFR mutation status and the risk of brain metastasis in patients with lung adenocarcinoma",
        "Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations",
        "Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer",
        "Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: Risk factors analysis",
        "Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma",
        "Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases",
        "Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation",
        "Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: Primary tumor size, cell type, and lymph node metastases",
        "The biology of brain metastases-translation to new therapies",
        "Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta- Analysis of Observational Studies with 4118 Cases",
        "Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression",
        "Brain metastases in patients with non-small cell lung cancer: The role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination",
        "Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma",
        "Factors associated with the development of brain metastases: Analysis of 975 patients with early stage nonsmall cell lung cancer",
        "The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy",
        "A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: Is EGFR mutation associated with a higher incidence of brain metastasis?",
        "Frequent EGFR mutations in brain metastases of lung adenocarcinoma",
        "Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer",
        "EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?",
        "Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers",
        "Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer",
        "TAM receptor tyrosine kinases: Biologic functions, signaling, and potential therapeutic targeting in human cancer",
        "Expression of axl in lung adenocarcinoma and correlation with tumor progression",
        "Biomarkers for epithelial-mesenchymal transitions"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn Academic Advancement",
        "Ratchadapiseksompotch Endowment Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}